
Greatly improves the individual's reaction time, decreasing the time taken to react by 300% "Spartan time". "improved colloidal neural disunification solution" drug.

Increased density of individual's muscles, greatly enhancing physical strength.Ĭolor sharpness is significantly improved upon, and night vision is heightened. Skeletons become virtually unbreakable, allowing survival in harder impacts. "carbide ceramic ossification catalyst" drug.

As a result, the candidates had the bodies of near-adult Olympic athletes at an average of only twelve years of age, and it took some time for them to acclimatize to their larger physiques. As puberty had not yet started for the majority of candidates at this time, they were given human growth hormone as well as cartilage, muscle and bone supplements added into their food over several months to artificially induce the onset of puberty. The schedule of the SPARTAN-III program was accelerated from that of the Spartan-IIs: because the Office of Naval Intelligence wanted to have the Spartans deployed in the field as rapidly as possible, by the time of Gamma Company the Spartan-IIIs were augmented at an average age of twelve, whereas the Spartan-IIs were fourteen during their augmentations. The Spartan-III candidates' ages upon induction typically ranged from four to six years old, with the nominal ages of some of them (such as Carter-A259) exhibiting more extreme deviation from the standard age range. While the CHRYSANTHEMUM augmentations still had to be administered at the onset of puberty as the bodies of either prepubescents or adults would reject the chemicals, Colonel Ackerson's age restriction protocol for the SPARTAN-III program was considerably looser than that of the Spartan-IIs. As a result of the more lenient selection criteria, the Spartan-III candidate pool was less physically and psychologically consistent, with a higher likelihood of behavioral problems many of the Spartan-III candidates were more lively and predisposed for aggression than their forebears. Colonel James Ackerson, the mastermind of the SPARTAN-III program, requested to have mandatory genetic screening put in place in the Outer Colonies in order to find more genetic matches for his program, but the Office of Naval Intelligence leadership felt this would only provoke the colonists for further aggression against the UNSC. The genetic requirements for the Spartan-III candidates were loosened from the exceedingly strict criteria of the SPARTAN-II program, although the range of compatible individuals still remained incredibly narrow, and any aberrations from the required genetic set geometrically increased the failure rate. Most of the Spartan-IIIs' augmentations were chemically induced instead of surgically implanted like many of the Spartan-II enhancements. With advances in technology, the casualty rate for Spartan-III candidates was usually 0%, as opposed to the 56% casualty rate of the Spartan-IIs. The CHRYSANTHEMUM bioaugmentation set improved upon the augmentations of the SPARTAN-II program, pioneered by Dr.

Carter-A259 undergoing the Project CHRYSANTHEMUM augmentations.
